Viewing Study NCT02433392


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-01-31 @ 9:12 AM
Study NCT ID: NCT02433392
Status: TERMINATED
Last Update Posted: 2021-04-21
First Post: 2015-04-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.
Sponsor: Boston Scientific Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module